Mendelsohn Aaron 4
4 · Vivani Medical, Inc. · Filed Aug 31, 2022
Insider Transaction Report
Form 4
Mendelsohn Aaron
Director
Transactions
- Other
Warrants
2022-08-30+25,927→ 25,927 total(indirect: See Footnote)Exercise: $3.15From: 2022-08-30Exp: 2023-12-14→ Common Stock (25,927 underlying) - Other
Common Stock
2022-08-30+150,930→ 150,930 total(indirect: By Trust) - Other
Common Stock Option
2022-08-30+30,187→ 30,187 totalExercise: $3.15From: 2022-08-30Exp: 2028-11-13→ Common Stock (30,187 underlying) - Other
Common Stock
2022-08-30+178,170→ 178,170 total - Other
Common Stock
2022-08-30+747,387→ 747,387 total(indirect: See Footnote) - Other
Common Stock Option
2022-08-30+30,187→ 30,187 totalExercise: $3.15From: 2022-08-30Exp: 2029-11-11→ Common Stock (30,187 underlying) - Other
Common Stock Option
2022-08-30+30,187→ 30,187 totalExercise: $3.15From: 2022-08-30Exp: 2030-11-19→ Common Stock (30,187 underlying)
Footnotes (6)
- [F1]Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated August 30, 2022.
- [F2]Represents five trusts, each one established for a separate grandchild of the Reporting Person, each trust owning an aggregate of 30,186 shares of common stock, all trusts with the same terms, over which the Reporting Person has voting and dispositive authority.
- [F3]Represents shares of common stock owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of the limited liability company and therefore 149,478 shares of common stock held by the limited liability company, which are beneficially owned by other members of the limited liability company.
- [F4]Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022.
- [F5]Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022.
- [F6]Represents shares of common stock underlying a warrant owned by MFE, LLC over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims pecuniary interest in 20% of the limited liability company and therefore 5,185 shares of common stock held by the limited liability company, which are beneficially owned by other members of the limited liability company.